JP2017520572A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017520572A5 JP2017520572A5 JP2016575171A JP2016575171A JP2017520572A5 JP 2017520572 A5 JP2017520572 A5 JP 2017520572A5 JP 2016575171 A JP2016575171 A JP 2016575171A JP 2016575171 A JP2016575171 A JP 2016575171A JP 2017520572 A5 JP2017520572 A5 JP 2017520572A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- hsv
- seq
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14174174.4 | 2014-06-26 | ||
| EP14174174 | 2014-06-26 | ||
| PCT/EP2015/064378 WO2015197763A1 (en) | 2014-06-26 | 2015-06-25 | Topical application for an anti-hsv antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017520572A JP2017520572A (ja) | 2017-07-27 |
| JP2017520572A5 true JP2017520572A5 (https=) | 2018-04-19 |
| JP6649284B2 JP6649284B2 (ja) | 2020-02-19 |
Family
ID=51032986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016575171A Active JP6649284B2 (ja) | 2014-06-26 | 2015-06-25 | 抗ｈｓｖ抗体の外用適用 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11267871B2 (https=) |
| EP (1) | EP3160997B1 (https=) |
| JP (1) | JP6649284B2 (https=) |
| KR (1) | KR102622280B1 (https=) |
| CN (2) | CN106488931B (https=) |
| AU (1) | AU2015279212B2 (https=) |
| CA (1) | CA2950489C (https=) |
| ES (1) | ES2843277T3 (https=) |
| NZ (1) | NZ726168A (https=) |
| RU (1) | RU2703903C2 (https=) |
| SG (1) | SG11201610320RA (https=) |
| WO (1) | WO2015197763A1 (https=) |
| ZA (1) | ZA201607813B (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3055555A1 (en) | 2016-03-11 | 2017-09-14 | Scholar Rock, Inc. | Tgf.beta.1-binding immunoglobulins and use thereof |
| EP3566749A4 (en) * | 2017-01-09 | 2020-09-23 | Medshine Discovery Inc. | THIAZOLE DERIVATIVE AND USES OF IT |
| US11472867B2 (en) | 2017-08-30 | 2022-10-18 | Km Biologics Co., Ltd. | Anti-HSV GB monoclonal antibody or antigen-binding fragment thereof |
| US12247066B2 (en) | 2018-08-28 | 2025-03-11 | Pontificia Universídad Católica de Chile | Monoclonal antibody 14F5F6 or fragment thereof, that specifically recognizes herpes simplex virus 1 and 2 |
| WO2020041911A1 (es) * | 2018-08-28 | 2020-03-05 | Pontificia Universidad Catolica De Chile | Anticuerpo monoclonal 11b2c7 o fragmento del mismo, que reconoce específicamente virus herpes simple 1 y 2 |
| EP3941524A1 (en) * | 2019-03-19 | 2022-01-26 | Albert Einstein College of Medicine | Monoclonal antibodies for prevention and treatment of herpes simplex viral infections |
| WO2022002802A1 (en) * | 2020-06-29 | 2022-01-06 | Glaxosmithkline Biologicals Sa | HSV gEgI HETERODIMER ANTIBODIES |
| TW202406932A (zh) | 2020-10-22 | 2024-02-16 | 美商基利科學股份有限公司 | 介白素2-Fc融合蛋白及使用方法 |
| US20260001939A1 (en) * | 2022-03-02 | 2026-01-01 | Heidelberg Immunotherapeutics Gmbh | Vaccine comprising an antibody or an fc-containing fusion protein comprising an fc part of an antibody |
| TW202426053A (zh) * | 2022-09-02 | 2024-07-01 | 聯合生物製藥股份有限公司 | 單純皰疹病毒感染的治療 |
| EP4727967A1 (en) | 2023-06-16 | 2026-04-22 | Heidelberg ImmunoTherapeutics GmbH | Novel anti-hsv antibody |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995018634A1 (en) * | 1994-01-04 | 1995-07-13 | The Scripps Research Institute | Human monoclonal antibodies to herpes simplex virus and methods therefor |
| EP1222281B1 (en) * | 1999-09-30 | 2006-11-15 | University of Washington | Immunoligically significant herpes simplex virus antigens |
| EA013564B1 (ru) * | 2000-08-03 | 2010-06-30 | Терапеутик Хьюман Поликлоналз Инк. | Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция |
| US20070274997A1 (en) | 2003-07-25 | 2007-11-29 | Anthony Simmons | Compositions and Methods for Herpes Simplex Prophylaxis and Treatment |
| US6984492B2 (en) * | 2003-09-05 | 2006-01-10 | Talecris Biotherapeutics, Inc. | Methods and compositions for treating herpes infections |
| WO2010129033A2 (en) | 2009-04-29 | 2010-11-11 | Calmune Corporation | Modified antibodies for passive immunotherapy |
| PL2248825T3 (pl) * | 2009-05-04 | 2013-04-30 | Ribovax Biotechnologies Sa | Fragmenty przeciwciała wiążące antygen do zastosowania w leczeniu i diagnozowaniu chorób oczu |
| EP2308895A1 (en) * | 2009-10-01 | 2011-04-13 | Universität Duisburg-Essen | Anti-HSV antibody |
| EP2694542A4 (en) * | 2011-04-08 | 2014-10-08 | Univ Duke | HERPES SIMPLEX VIRUS |
-
2015
- 2015-06-25 NZ NZ726168A patent/NZ726168A/en unknown
- 2015-06-25 SG SG11201610320RA patent/SG11201610320RA/en unknown
- 2015-06-25 CN CN201580034015.2A patent/CN106488931B/zh active Active
- 2015-06-25 CA CA2950489A patent/CA2950489C/en active Active
- 2015-06-25 CN CN202210007608.1A patent/CN114306596A/zh active Pending
- 2015-06-25 RU RU2017102387A patent/RU2703903C2/ru active
- 2015-06-25 WO PCT/EP2015/064378 patent/WO2015197763A1/en not_active Ceased
- 2015-06-25 AU AU2015279212A patent/AU2015279212B2/en active Active
- 2015-06-25 US US15/320,501 patent/US11267871B2/en active Active
- 2015-06-25 EP EP15733409.5A patent/EP3160997B1/en active Active
- 2015-06-25 KR KR1020177000526A patent/KR102622280B1/ko active Active
- 2015-06-25 JP JP2016575171A patent/JP6649284B2/ja active Active
- 2015-06-25 ES ES15733409T patent/ES2843277T3/es active Active
-
2016
- 2016-11-11 ZA ZA2016/07813A patent/ZA201607813B/en unknown
-
2022
- 2022-02-18 US US17/675,329 patent/US20220169705A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017520572A5 (https=) | ||
| RU2017102387A (ru) | Местное применение антитела к hsv | |
| CO2020014727A2 (es) | Anticuerpo anti proteína reguladora de señales alfa sirpαlfa | |
| JP2018503361A5 (https=) | ||
| JP2020536109A5 (https=) | ||
| JP2020518599A5 (https=) | ||
| PE20181270A1 (es) | Anticuerpo que neutraliza el virus respiratorio sincitial humano | |
| JP2018506966A5 (https=) | ||
| PE20170687A1 (es) | Proteinas de enlace a cd127 | |
| PE20090518A1 (es) | Proteinas enlazantes de antigenos que enlazan al receptor de la interleucina 18 (il-18) | |
| JP2015178529A5 (https=) | ||
| JP2015522252A5 (https=) | ||
| EA200970586A1 (ru) | Антитела к цитомегаловирусу человека (hcmv) | |
| CO6690799A2 (es) | Composiciones de anticuerpo anti - cmv y métodos de uso | |
| JP2019534003A5 (https=) | ||
| WO2013165982A3 (en) | Anti-human cytomegalvirus antibodies and use thereof | |
| PE20221865A1 (es) | Anticuerpos contra el virus de la fiebre amarilla y metodos de su generacion y uso | |
| JP2021511043A5 (https=) | ||
| IL275884B2 (en) | Human antibodies to influenza hemagglutinin | |
| JP2024518536A5 (https=) | ||
| AR116053A1 (es) | Anticuerpo monoclonal específico contra el antígeno n del virus respiratorio sincicial humano (vrsh), útiles para el tratamiento de la infección, su detección y diagnóstico | |
| JP2020507338A5 (https=) | ||
| EP4727967A1 (en) | Novel anti-hsv antibody | |
| RU2012146085A (ru) | МОНОКЛОНАЛЬНОЕ АНТИТЕЛО, НАПРАВЛЕННОЕ ПРОТИВ БЕЛКА р17 ВИЧ, СПОСОБНОЕ НЕЙТРАЛИЗОВАТЬ СВЯЗЫВАНИЕ р17 С РЕЦЕПТОРОМ р17 (р17R) | |
| RU2019115249A (ru) | Антитела к респираторно-синцитиальному вирусу и способы их получения и применения |